BACKGROUND: The effects of perinatal antiretroviral therapy (ART) on infant mitochondrial function are not well known. We compared blood mitochondrial DNA (mtDNA) levels and mtDNA gene expression (mtRNA) in human immunodeficiency virus (HIV)-uninfected, ART-exposed infants born to HIV-positive mothers with mtDNA levels and mtDNA gene expression in control infants born to uninfected women. METHODS: In this prospective cohort study, longitudinal mtDNA:nuclear DNA and mtRNA:beta-actin mRNA ratios were compared in blood samples obtained at various time points from birth to 8 months, using generalized estimating equation linear regression models. RESULTS: Log(10) mtDNA levels at birth were higher in ART-exposed infants, compared with levels in control infants, although the difference did not reach statistical significance (P = .07 for comparison of samples obtained 0-3 days after birth). ART-exposed infants' mtDNA levels increased further during the zidovudine prophylaxis period-from age 4 days to age 6 weeks-(P = .001) and remained significantly higher than the levels observed in control infants until the end of the study. In contrast, log(10) mtRNA levels at birth were lower in ART-exposed infants than in control infants (P = .03), but were not statistically different later. CONCLUSIONS: When control infants and ART-exposed infants were compared, the mtDNA level was increased but mitochondrial gene expression was decreased in ART-exposed infants. These differences persisted after zidovudine was discontinued, suggesting that changes in mitochondrial proliferation and/or expression take place during and after ART exposure. These changes are likely the effects of the antiretroviral drugs on mitochondria. The clinical relevance and long-term impact of these alterations must be studied.
BACKGROUND: The effects of perinatal antiretroviral therapy (ART) on infant mitochondrial function are not well known. We compared blood mitochondrial DNA (mtDNA) levels and mtDNA gene expression (mtRNA) in human immunodeficiency virus (HIV)-uninfected, ART-exposed infants born to HIV-positive mothers with mtDNA levels and mtDNA gene expression in control infants born to uninfected women. METHODS: In this prospective cohort study, longitudinal mtDNA:nuclear DNA and mtRNA:beta-actin mRNA ratios were compared in blood samples obtained at various time points from birth to 8 months, using generalized estimating equation linear regression models. RESULTS: Log(10) mtDNA levels at birth were higher in ART-exposed infants, compared with levels in control infants, although the difference did not reach statistical significance (P = .07 for comparison of samples obtained 0-3 days after birth). ART-exposed infants' mtDNA levels increased further during the zidovudine prophylaxis period-from age 4 days to age 6 weeks-(P = .001) and remained significantly higher than the levels observed in control infants until the end of the study. In contrast, log(10) mtRNA levels at birth were lower in ART-exposed infants than in control infants (P = .03), but were not statistically different later. CONCLUSIONS: When control infants and ART-exposed infants were compared, the mtDNA level was increased but mitochondrial gene expression was decreased in ART-exposed infants. These differences persisted after zidovudine was discontinued, suggesting that changes in mitochondrial proliferation and/or expression take place during and after ART exposure. These changes are likely the effects of the antiretroviral drugs on mitochondria. The clinical relevance and long-term impact of these alterations must be studied.
Authors: A C Ross; T Leong; A Avery; M Castillo-Duran; H Bonilla; D Lebrecht; U A Walker; N Storer; D Labbato; A Khaitan; I Tomanova-Soltys; G A McComsey Journal: HIV Med Date: 2011-11-21 Impact factor: 3.180
Authors: Abhinav Ajaykumar; Hugo Soudeyns; Fatima Kakkar; Jason Brophy; Ari Bitnun; Ariane Alimenti; Arianne Y K Albert; Deborah M Money; Hélène C F Côté Journal: J Infect Dis Date: 2018-02-14 Impact factor: 5.226
Authors: Abhinav Ajaykumar; Mayanne Zhu; Fatima Kakkar; Jason Brophy; Ari Bitnun; Ariane Alimenti; Hugo Soudeyns; Sara Saberi; Arianne Y K Albert; Deborah M Money; Hélène C F Côté Journal: J Infect Dis Date: 2021-02-24 Impact factor: 5.226
Authors: Jennifer Jao; Kathleen M Powis; Brian Kirmse; Chunli Yu; Fanny Epie; Emmanuel Nshom; Elaine J Abrams; Rhoda S Sperling; Derek Leroith; Mitchell E Geffner; Irwin J Kurland; Hélène C F Côté Journal: AIDS Date: 2017-11-28 Impact factor: 4.177
Authors: Susan B Brogly; Salvatore DiMauro; Russell B Van Dyke; Paige L Williams; Ali Naini; Daniel E Libutti; Julia Choi; Michelle Chung; Mariana Gerschenson Journal: AIDS Res Hum Retroviruses Date: 2011-01-15 Impact factor: 2.205
Authors: Hélène C F Côté; Mariana Gerschenson; Ulrich A Walker; Oscar Miro; Gloria Garrabou; Emma Hammond; Joan Villarroya; Marta Giralt; Francesc Villarroya; Paola Cinque; Elena Garcia-Arumi; Antonio L Andreu; Marcello Pinti; Andrea Cossarizza Journal: Mitochondrion Date: 2011-02-22 Impact factor: 4.160
Authors: Thor A Wagner; Chen-Han Lin; Nicole H Tobin; Hélène C F Côté; Derek D Sloan; Keith R Jerome; Lisa M Frenkel Journal: Cytometry B Clin Cytom Date: 2012-10-08 Impact factor: 3.058